chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ON 3/28/18 PATIENT PRESENTED TO PCP. PATIENT RECEIVED ONE IM INJECTION OF DILUENT IN LEFT DELTOID IN ERROR (PER OFFICE VACCINE WAS NOT RECONSTITUTED AT THIS TIME). ERROR IDENTIFIED IMMEDIATELY, AND PATIENT ADMINISTERED SHINGRIX VACCINE IM IN LEFT DELTOID SHORTLY AFTERWARDS ON 3/28/18 ~ 1650.  ON 3/29/18 ~ 1100, PATIENT ENDORSED FEELING DIZZY, GENERALIZED WEAKNESS, FAINTED, ABNORMAL SKIN FEELING, AND JOINT PAIN. NO OTHER SYMPTOMS ENDORSED. PATIENT PRESENTED TO ED FOR FOLLOW UP.  VS STABLE. PATIENT ADMINISTERED 1L LR BOLUS. CMP/CBC NORMAL. PATIENT DISCHARGED ~1500 IN STABLE CONDITION WITH INSTRUCTIONS TO FOLLOW UP WITH PCP IF SYMPTOMS WORSENED.
On day two after vaccine given, a 2 inch wheal developed and remained until day 6, red and itching at site.
pt recv 29MAY98 & 14hr later 30MAY98 1:30 pt devel diarrhea & nausea which lasted until 2:00;over the peirod of the next 3hr 5:00 30MAY98 pt also devel vomiting, backache, h/a, low grade fever, chills, sweats, lackof appetite;pt not hosp;
patient presented with alot of anxiety about vaccine.  Vaccine was administered at 10:50am. We discussed vaccine and she was happy to get it.  After giving her her dose, she called nurse over to say that she didn't feel well.  Patient continued to state that her throat felt weird, she felt like throwing up, it was hard to swallow, and that she was sweaty.  She said she had a nervous cough. At 10:20 Am we checked her BP - it was 141/115 and her pulse was 63.  She asked for epipen but didn't truly need at the time - said her breathing was fine.  At 10:31 Am her pulse was 59 and BP 128/84.  She got an ice pack after offering a couple times at 10:31.  911 Was called at 11:05 Am because patient still stated she didn't feel right.
Patient received the pfizer covid booster on November 30,2021 and she had an allergic reaction. Within 5 minutes her throat started closing up, her heart was racing, her lips were swollen and her oxygen decreased. She said with each pfizer shot the reaction was getting worse until her last booster. She was hospitalized, put on iv fluids and given epipen, then sent home.
I received my shot at 2:30 pm. A few hours later my arm was very painful. I could hardly move my arm and it kept me up all night. Around 4 am I had a sore throat and a stuffy nose. At about 7 am I had a headache, fever of 37.6 Celsius, chills, and horrible body aches.
Narrative:  Patient contacted patient response center in July 2021 reporting fatigue, palpitations, and shortness of breath. PCP notified, recommended follow up by pulmonary.
Myocarditis.  Pt received 2nd Dose Moderna on 4/21/21 morning.  He reported developing fever of 102 F on 4/22/21.  He reported developing chest pain early morning on 4/23/21.  Denied other symptoms.  Pt went to urgent care due to chest pain and SOB.  Pt sent to ED from urgent care due to abnormal EKG.  EKG showed ST elevation.  Troponin I elevated 13.0 .  C-reactive protein elevated 8.22.  Left heart cath done, normal.  CT PE done to rule out PE.  Pt diagnosed with myocarditis and severe inflammation.  "Elevated Inflammatory markers possibly related to COVID vaccine."
Client was given pediatric Pfizer in error as client was 14 years old. Mom was notified that child was too old the day before clinic and was cancelled but mom brought child and showed previous confirmation so child was vaccinated in error.
pt recvd vax; exp large inject site rxn; also c/o chills on spine; pulse rate 106; could not sleep;
Nosebleed on morning of 17 June 2006; petechiae developed on evening of 17 June 2006, so patient went to ER; Idiopathic Thrombocytopenic Purpura was diagnosed. She was admitted and treated with platelet transfusion, IVIG, and IV corticosteroids. 7/18/06-Presented to ED with petechial rash. Plt on admission 3000. Admitting DX thrombocytopenia. PMH: hypothyroidism and osteopenia. Recently visited foreign country. Received 1st dose of encephalitis vaccine on 6/6/06 and 2nd dose 6/12/06 with 3rd dose scheduled week of 6/25/06. Hematology and Infectious Disease consults requested.  PSH: Status post repair of deviated septum in 1994 with hemorrhage status post right 5th to hammer toe repair. Skin biopsy 1 week prior to this admission no firm diagnosis with possible diagnosis of lichen sclerosis. Current Meds: Fosamax and Synthroid. PE normal with petechia on the oral mucosa and 2 sits of what appear to have been blood blisters the overlying mucosa of which is torn.  7/26/06-a DC summary is not dictated for a stay of 48 hours or <. Med Rec will fax DC face sheet that includes DC DX.  8/1/06-DC DX received from hospital: Principal DX: Other and unspecified complication of medical care. Secondary DX: immune thrombocytopenic purpura and unspecified acquired hypothyroidism.
pt recv vax & devel swollen knee;the reporting rheumatologist aspirated fluid from the knee, which contained 15,000 white blood cells;pt is being treated w/ATB
I gave 3 shots to a couple, I gave a FLUZONE HIGH dose to wife, then told her to sit down at pharmacy bench and I gave husband 2 shots of FLUZONE HIGH DOSE and PREVNAR 13. I told husband to wait 20 minutes before leaving, after 20 minutes, I went to the bench where couple sit and ask How are they doing? wife said I dont feel too well, she said her heart is fluttering. So I checked her blood pressure, it was 183/119, I freaked out; but wife said she can take her clonidine (in her purse). After 15 mins, I checked her blood pressure again, it was 172/138, I totally freaked out and I tell couple that I should call 911 but they said they wouldn't go to ER. So I came back to pharmacy, told pharmacist and lead tech. Lead tech called management, 2 male managers came but patient decline medical help (going to ER). After 30 mins, I think clonidine is kicked in by now, I checked her bp again, this time it was 168/90. The wife said she felt ok now and they want to go home. I asked them to stay but they said they would go home, so I told husband to watch his wife while driving home and told wife to check her blood pressure when she arrived and call me, but she didn't call. After 1 hour, after I came back from lunch, I called her and told her to check her blood pressure, it was 138/80, and patient said she felt ok now, no injection size reactions, and her heart is ok.
copious watery non-bloody, non-mucoid diarrhea w/no emesis about 8-10times day;pt fussy, variable feeding lasting 2 days adm for observation;
Information has been received from a hospital pharmacy technician via a pulmonologist concerning a 57 year old male who was vaccinated with a dose of PNEUMOVAX 23 (Lot #658175/0856U).  Subsequently the patient "got sick" and required bed rest.  "He felt he developed pneumonia that nearly killed him".  He was on an unspecified antibiotic for 2 weeks.  At the time of the report the patient's outcome was unknown.
Systemic: Headache-Medium, Systemic: Joint Pain-Medium, Additional Details: Headache and jaw pain lasting for over 3 weeks at this point - ongoing
10 days after vaccination developed high fever (above 103) with a hard knot remaining in the leg the Pediarix was given.  Symptoms lasted 5 days.  Saw the doctor, treated with tylenol and motrin.
Pt presented to the pharmacy on 8/26 with prescriptions (2 days after the PPSV vaccination) for antibiotic and steroid cream. He stated that his right arm has become swollen and itching after receiving the PPSV 23 vaccine and so he went to the local emergency room and was given those 2 prescriptions for his problem. He said the swelling and itching is improving but has not completely resolved.
2019 Novel Coronavirus RNA detected 11/30/2021 Hospitalized 11/30/2021 with pneumonia
Patients received the Moderna Covid 19 vaccine after temperature excursion; Patients received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In April 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion). On 26-Apr-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that there had been temperature excursions with the freezer that was happened for weeks since April 2022. Storage condition at the time of the excursion were frozen.  It was reported that Lot numbers: 065K21A and Lot numbers 045L21A had undergone temperature excursion and maximum and minimum temperatures reached were 30 Fahrenheit Degrees and minus 18.9 Fahrenheit Degrees respectively.  It was reported that the vaccines suffered 2 temperature excursions since April, both lasted less than 1 minute and they were stored in frozen condition and no vaccine state change was observed through visual inspection.  No treatment medications were reported.
tested positive for COVID; positive COVID-19 test with no symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 13 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "tested positive for COVID"; ASYMPTOMATIC COVID-19 (medically significant), outcome "unknown", described as "positive COVID-19 test with no symptoms". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Clinical course: learned yesterday that my friend's daughter, 13, tested positive for COVID (she was exposed at school). She received 2 doses of Comirnaty and was recently boosted. She is symptom free. The lot number for bnt162b2 was not provided and will be requested during follow up.
Macular rash on all extremities, torso, neck and face which also led to urticaria on day #2.
Final dx atypical sz/viral synd; fever for 2 days a/hosp admission; mom states pt had fever of 105 on admission to ER;
This spontaneous report was received from a medical assistant and refers to a 26 year old male patient, who is a pharmacy student. The patient's concurrent conditions included neuropathy peripheral, intervertebral disc disorder and some others not reported. The patient had none drug reactions/allergies. Concomitant therapies included diphenhydramine hydrochloride (BENADRYL), montelukast sodium (SINGULAIR), cetirizine hydrochloride (ZYRTEC), gabapentin, tramadol hydrochloride and melatonin. Approximately in 1996 (reported as at an unspecified time in 1996 and 1997), the patient was vaccinated with VARIVAX (dose, route, lot # and expiration date were not reported) for prophylaxis. Approximately on 27-MAR-2017 (reported as about a week ago), the patient had varicella titers drawn and the titers showed lack of immunity to varicella (antibody test negative). The patient sought medical attention by visiting the office. On 03-APR-2017, the patient received a dose of VARIVAX (dose not reported) (lot # M002064 and expiration date 12-JAN-2018) in response to the low titers. The patient was inadvertently vaccinated by intramuscular route. The outcome of the event antibody test negative was unknown. It was reported that the patient was doing fine at the time of this report. The causality between the event and VARIVAX was not reported. Additional information has been requested.
Very painful at injection site, severe chills, severe body aches and headache, low-grade fever (100)
Initial unsolicited case received from a healthcare professional (medical assistant) on 25 February 2015. A 54-year-old female patient, with a history of asthma, hypothyroidism, obesity, optic neuritis, depression, and generalized chronic pain, received a left arm (upper shoulder) intramuscular injection of FLUZONE (lot number UI189AA) on 08 September 2014. On 29 December 2014, the patient presented to her physician with complaints of left shoulder pain which she thought was related to her flu shot. An x-ray of the shoulder was negative. She returned to her physician on 28 January 2015 with the same complaints, at which time she was given a steroid injection in the left shoulder. On 24 February 2015 she again saw her physician with the same complaint, and was prescribed NAPROSYN and VOLTAREN Gel. An MRI of the shoulder was ordered; results were pending at the time of the report. The reporter noted that the patient had not self-treated for pain with NSAIDS or acetaminophen. Concomitant medications included AMBIEN, PROVENTIL inhaler, SYNTHROID, and SINGULAIR. Outcome was reported as unknown. Documents held by sender: None.
Employee received his first dose of hepatitis B vaccine at 3 PM on 2/6/2023 at Occupational Health.  Approximately 45 minutes to 1 hour later he presented to my office complaining of palpitations, sweating and mild lightheadedness.  He denied chest pain, difficulty breathing, difficulty swallowing or rash.  Heart rate was 130 and regular, blood pressure 140/90.  He was given water and a piece of chocolate.  He laid down on the stretcher and within 30 minutes his heart rate was down to 100 and his blood pressure 130/80.  We discussed returning to work versus going home.  He felt able to go to work.  I called him from home 2 hours later and he was feeling better but not 100%. He stop by my office the following afternoon and felt back to his normal self.  He had no other symptoms.  He agreed with the plan not to complete the series.
severe allergic reaction:  painful, itchy, runny eyes, nasal congestion, wheezing
Headache, Rash pruritis Narrative:  reported to EOH 8/27 to report. Plans to talk to doctor to decide second dose. Alternative CV Received Syphillis vaccine and Tdap on8/13/2021 d/t work related exposure
Pt states that he woke up the next morning and his entire left arm was swollen and numb. The following day, two days after the vaccination, the entire left side of his body was swollen and numb. The patient went to the hospital on April 6, 2021, and was hospitalized for ten days. Upon admission, he had bloody urine, swelling and numbness on the left side of his body, and was short of breath and coughing up blood. Pt was diagnosed with pneumonia while admitted to hospital.
I had my 4th vaccine on November 8th, 2023. Initially after the bivalent vaccine, I had Covid-19 symptoms, which I assumed was normal. These lasted a long time and progressed to worse symptoms. Within three weeks, I had significant shortness of breath (even to speak), exertion intolerance, and racing heart without exertion. I stood up from a chair and my heart raced over 130. I saw a Cardiologist on Nov. 28. He did tests to rule out heart muscle damage- labs for Cardiac Inflammation and D- Dimer. By the next day, I learned my D Dimer was between 900-950. I was still very symptomatic and had to go to the Emergency Room to rule out PE- THE SAME THING THAT HAPPENED AFTER MY 3RD VACCINE, BUT WORSE. I was in the hospital for 3 days.
This case was reported by a consumer and described the occurrence of injection site pain in a 55-year-old female patient who received SHINGRIX. On 30th April 2018, the patient received the 1st dose of SHINGRIX. On 30th April 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The reporter's sister experienced pain on injection.
Body aches, chills, headache  (2 days), body shaking/ tremors constantly (5days)
Slight swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Slight swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included Bruise, Abdominal discomfort and Swelling.    On 25-Feb-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Slight swelling). At the time of the report, VACCINATION SITE SWELLING (Slight swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-034823 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: ADR form with pictures
Patient  received expired vaccine, no  s/s of  any effects  or  reaction.  Patient is doing well,  no  distress noted  or reported.  Patient  was  updated.
passed out; nauseous; vomited; had a very intense headache; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, 027H21B and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache). At the time of the report, LOSS OF CONSCIOUSNESS (passed out), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.  Company Comment: This case concerns a 49-year-old female patient with no medical history, who experienced the unexpected event of Loss of consciousness and the expected events of Nausea, Vomiting and Headache. The events occurred 15 hours after the second dose of mRNA-1273 Vaccine. The rechallenge is not applicable since no further dosing is expected. At the time of the report the outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2021-406048 (Patient Link).; Sender's Comments: This case concerns a 49-year-old female patient with no medical history, who experienced the unexpected event of Loss of consciousness and the expected events of Nausea, Vomiting and Headache. The events occurred 15 hours after the second dose of mRNA-1273 Vaccine. The rechallenge is not applicable since no further dosing is expected. At the time of the report the outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Patient passed out a couple minutes post vaccination and recovered quickly. Patient's face was pale, feeling nauseous, no EPIpen was given as this doesn't manifest allergic reaction. Patient was given alcohol pad to smell on to reduce nauseous feeling and bottle of ice water. Patient recovered quickly after 10 minutes and was observed for additional 10 minutes, she was alert and was walking around the store.
Attack muscles and joints throughout body, in constant pain; Contracted covid; Initial information received on 04-Mar-2022 regarding an unsolicited valid non-serious case received via consumer/non-hcp(health care professional).  This case involves a 57 years old male patient who experienced attack muscles and joints throughout body, in constant pain and contracted covid while receiving vaccine Tetanus Toxoid.  The patient's past medical history, concomitant drugs, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TETANUS TOXOID (strength, dose, and route: unknown) produced by unknown manufacturer lot number not reported in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious "attack muscles and joints throughout body, in constant pain" (pain)(unknown latency) and "contracted covid (covid-19)" (unknown latency) following the administration of TETANUS TOXOID.  It was reported that "I think I contracted covid twice since October 2019 and September 2022. I am not vaccinated. In January 2019, I recieved a TDap booster that has attack my muscles and joints throughout my body. i am in constant pain. I was on steroids until February 2022. I take Naprosyn for pain. I would like to become vaccinated. But I am extremely nervous. I dont want to have a double bad reaction and maybe pass away. What do u think I should do ? "  Action taken: Unknown for both the events.  It was not reported if the patient received a corrective treatment for the event (Contracted covid) and received a corrective treatment naproxen (Naprosy) for the event Attack muscles and joints throughout body, in constant pain  At time of reporting, the outcome was Unknown for both the events
Fever and chills, treated with acetaminophen and ibuprofen. Later 24 hours initially,atarting at 5 am on 12/22/2021. Resumed 1 pm 12/23.2021 and lasted until 4 am 12/24/2021. Highest temp recorded 102.7, average about 101.
1. Sporadic palpitations,  skipping heart beats associated with chest pressure and choking sensation on throat lasting a few seconds, causing a sense of impending doom.  2. Cough with wheezing
Flu like symptoms; fever; body aches; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: ENG208) via unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient did not have allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ADDERALL for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ENG202) via an unspecified route of administration in the left arm on 27Feb2021 at 11:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 20Mar2021 at 23:30, the patient experienced flu like symptoms, fever and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received ibuprofen as treatment for the events. The clinical outcome of the events flu like symptoms, fever and body aches were recovering.   No follow-up attempts are possible. No further information is expected.